Skip to main content
. 2021 Feb 24;137:109613. doi: 10.1016/j.ejrad.2021.109613

Table 3.

Parenchymal stages and pulmonary embolism.

Total (n = 114) PE (n = 65) Non-PE (n = 49) p-value (p < 0.001)
Stages 0.229
Early 6 (5.3 %) 1 (1.5 %) 5 (10.2 %)
Progressive 26 (22.8 %) 16 (24.6 %) 10 (20.4 %)
Peak 74 (64.9 %) 44 (67.7 %) 30 (61.2 %)
Absorption 8 (7%) 4 (6.2 %) 4 (8.2 %)

Data presented as n (%). Differences with two-sided p-values above 0.001 not deemed as statistically strongly significant.